Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY

STEIN-STREILEIN, JOAN, STREILEIN, J. WAYNE · 2002 · International Reviews of Immunology

Abstract

Immune privilege was first explored in the late 1800s by van Dooremaal, and was then extended by Medawar in the mid 1900s to fit in with emerging concepts of transplantation immunology. Modern concepts and understanding of immune privilege come from subsequent studies produced by Medawar, Billingham, and Streilein. The exploitation of the model of anterior chamber immune deviation (ACAID) in mice has allowed us to look at both cellular and molecular mechanisms involved in the prevention of potentially damaging immune responses in such privileged sites. This review gives a historical perspective of the immune privilege research and provides up-to-date information of molecules, cells, and concepts newly recognized as contributing to tolerance induction induced in such specialized areas of the body. Evidence is given to support the idea that application of such information may lead to potential for therapeutic applications of ACAID mechanisms in prevention of progression of immune-inflammatory diseases in humans.

Overview

Integrity signals

Registry

Crossref · 10.1080/08830180212066

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 132 references

Research works printed but not linked: 44

  1. van Dooremaal J.C., 1873, Akbrecg. Vab. Graefes Arch. Opthalomol., 19, 358
  2. P.B., 1945, London, 79, 157
  3. P.B., 1948, Pathol., 29, 58
  4. Streilein J.W., 1979, Masson et Cie, 174
  5. Asherson G.L., 1965, Immunology, 9, 205
  6. Niederkorn J., 1980, Invest. Opthalmol. Vis. Sci., 20, 355
  7. Whittum J.A., 1984, Invest. Opthalmol. Vis. Sci., 25, 1065
  8. McLeish W., 1989, Regional Immunol., 2, 236
  9. Niederkorn J.Y., 1990, Adv. Immunol., 48, 1999
  10. Mizuno K., 1989, Invest. Ophthalmol. Vis. Sci., 30, 1112
  11. Streilein J.W., 2001, Invest. Ophthalmol. Vis. Sci., 42, S523
  12. Jiang L.Q., 1991, Invest. Ophthalmol. Vis. Sci., 32, 224
  13. Jiang L.Q., 1993, Invest. Opthahalmol. Vis. Sci., 34, 3347
  14. Eichorn M., 1993, Invest. Ophthalmol. Vis. Sci., 34, 2926
  15. Kaiser C.J., 1985, Regional Immunol., 2, 42
  16. Taylor A.W., 1998, Invest. Opthahalmol. Vis. Sci., 39, 1372
  17. Miyamoto K.I., 1999, Invest. Ophthalmol. Vis. Sci., 40, S986
  18. Takeuchi M., 1999, Immunol., 98576
  19. Goslings R.O., 1998, Invest. Ophthalmol. Vis. Sci., 39, 989
  20. Cousins S.W., 1991, Invest. Ophthalmol. Vis. Sci., 32, 2201
  21. Biros D.J., 2001, Invest. Ophthalmol. Vis. Sci., 42, S929
  22. Knisely T.L., 1994, Invest. Opthalmol. Vis. Sci., 35, 3711
  23. Williamson S.P., 1989, Immunology, 67, 96
  24. H., 1989, The Journal of Immunology, 153, 1982
  25. Kezuka T., 2000, Immunology, 41, 1410
  26. Yao Y.F., 1997, Invest. Ophthalmol. Vis. Sci., 38, 534
  27. Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1803
  28. Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1410
  29. Waldrep J.C., 1984, Invest. Opthalmol. Vis. Sci., 25, 447
  30. Wilbanks G., 1990, Immunology, 71, 383
  31. Martin F., 2000, Immunol. Rev., 175, 70, 10.1111/j.1600-065X.2000.imr017515.x · doi:10.1111/j.1600-065x.2000.imr017515.x · Paper page
  32. Sonoda K.-H., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
  33. Sonoda K.-H., 2001, Stein-Streilein. J. Immunol., 166, 42
  34. Faunce D.E., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
  35. T., 1999, Cancer Res., 59, 5102
  36. Parker D.C., 1992, FASEB J., 131, 2777
  37. Wilbanks G.A., 1989, Regional Immunol., 2, 390
  38. Wilbanks G.A., 1990, Immunology, 71, 383
  39. 10.1146/annurev.iy.12.040194.004113 · doi:10.1146/annurev.iy.12.040194.004113 · Paper page
  40. Mosmann T.R., 1992, Sci., 664, 89
  41. Wilbanks G.A., 1990, Immunology, 71, 566
  42. Atherton S.S., 1987, Invest. Opthamol. Vis. Sci., 28, 859
  43. Rouse M.G., 1992, J. Immunol., 142, 3035
  44. Niederkorn J.Y., 1996, Invest. Ophthalmol. Vis. Sci., 37, 2700

Cited by

See all 218

Metadata

Authors
STEIN-STREILEIN, J., & STREILEIN, J. W.
Affiliations
Harvard University (US)
Venue
International Reviews of Immunology
Published
2002-01
Volume
21
Issue
2-3
Pages
123-152
ISSN
  • 0883-0185 (ISSN-L)
  • 1563-5244
OpenAlex
W1966161103
Cited by
218
References
132
Citations by year
2026: 4 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 11
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Locations
  • International Reviews of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
anterior chamber-associated immune deviation, immune privilege, tolerance induction, ocular immunology, transplantation immunology
MeSH terms
Animals, Anterior Chamber, Antigen-Presenting Cells, Eye Diseases, Graft vs Host Disease, Humans, Immune Tolerance, Killer Cells, Natural, Ovalbumin, T-Lymphocytes, Transplantation Immunology, Th1 Cells, Th2 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY. https://app.cochat.ai/papers/10.1080/08830180212066
The paper
STEIN-STREILEIN, J., & STREILEIN, J. W. (2002). ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY. International Reviews of Immunology. https://doi.org/10.1080/08830180212066

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.